BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24559606)

  • 1. Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort.
    Cox J; Maurais E; Hu L; Moodie EE; Law S; Bozinoff N; Potter M; Rollet K; Hull M; Tyndall M; Cooper C; Gill J; Saeed S; Klein MB;
    Drug Alcohol Depend; 2014 Apr; 137():121-8. PubMed ID: 24559606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
    Braitstein P; Li K; Kerr T; Montaner JS; Hogg RS; Wood E
    AIDS Care; 2006 Oct; 18(7):690-3. PubMed ID: 16971276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
    Zhang L; Celentano DD; Le Minh N; Latkin CA; Mehta SH; Frangakis C; Ha TV; Mo TT; Sripaipan T; Davis WW; Quan VM; Go VF
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):550-6. PubMed ID: 25769097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV and HCV prevalence and gender-specific risk profiles of crack cocaine smokers and dual users of injection drugs.
    Shannon K; Rusch M; Morgan R; Oleson M; Kerr T; Tyndall MW
    Subst Use Misuse; 2008; 43(3-4):521-34. PubMed ID: 18365948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort.
    Clausen LN; Weis N; Schønning K; Fenger M; Krarup H; Bukh J; Benfield T
    Scand J Infect Dis; 2011 Oct; 43(10):798-803. PubMed ID: 21728744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH; Murad S; Easterbrook PJ
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cedar Project: a comparison of HIV-related vulnerabilities amongst young Aboriginal women surviving drug use and sex work in two Canadian cities.
    Mehrabadi A; Craib KJ; Patterson K; Adam W; Moniruzzaman A; Ward-Burkitt B; Schechter MT; Spittal PM;
    Int J Drug Policy; 2008 Apr; 19(2):159-68. PubMed ID: 17870461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents.
    Alavi M; Raffa JD; Deans GD; Lai C; Krajden M; Dore GJ; Tyndall MW; Grebely J
    Liver Int; 2014 Sep; 34(8):1198-206. PubMed ID: 24164865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Food Insecurity in HIV-Hepatitis C Virus Co-infected Individuals in Canada: The Importance of Co-morbidities.
    Cox J; Hamelin AM; McLinden T; Moodie EE; Anema A; Rollet-Kurhajec KC; Paradis G; Rourke SB; Walmsley SL; Klein MB;
    AIDS Behav; 2017 Mar; 21(3):792-802. PubMed ID: 26912217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance Use Patterns of HIV-Infected Russian Women with and Without Hepatitis C Virus Co-infection.
    Brown JL; DiClemente RJ; Sales JM; Rose ES; Safonova P; Levina OS; Belyakov N; Rassokhin VV
    AIDS Behav; 2016 Oct; 20(10):2398-2407. PubMed ID: 26995679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hepatitis C virus infection: it is not only about the liver.
    Vigani AG; Tozzo R; Quezada A; Diaz AC; Mendes L; Lopes I; Riberio E; Espindola GM; Lopes FP; Petoilho EC; Queiroz JL; Castro HM
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):313-8. PubMed ID: 23719563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study.
    Ma H; Villalobos CF; St-Jean M; Eyawo O; Lavergne MR; Ti L; Hull MW; Yip B; Wu L; Hogg RS; Barrios R; Shoveller JA; Montaner JSG; Lima VD
    BMC Health Serv Res; 2018 May; 18(1):319. PubMed ID: 29720155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with geographic migration among a cohort of injection drug users.
    Rachlis BS; Hogg RS; Wood E; Li K; Kerr T
    Health Place; 2008 Sep; 14(3):536-43. PubMed ID: 18410717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility.
    Wood E; Kerr T; Stoltz J; Qui Z; Zhang R; Montaner JS; Tyndall MW
    Public Health; 2005 Dec; 119(12):1111-5. PubMed ID: 16214189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.
    Kalichman SC; Washington C; Kegler C; Grebler T; Kalichman MO; Cherry C; Eaton L
    Subst Use Misuse; 2015; 50(12):1536-43. PubMed ID: 26583598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rates of lifetime and recent violence observed among harder-to-reach women living with HIV.
    Borwein A; Salters KA; Palmer AK; Miller CL; Duncan KC; Chan K; Montaner JS; Hogg RS
    AIDS Care; 2014; 26(5):587-94. PubMed ID: 24111944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.
    Min JA; Yoon Y; Lee HJ; Choi J; Kwon M; Kim K; Lee CU; Kim DJ; Yun H
    J Med Virol; 2013 Apr; 85(4):575-82. PubMed ID: 23364858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.